Mutations in CARD11, CBM complex, ITAM, or SYK can give rise to “chronic active” BCR signaling and the activation of NF-κB, which is seen in the ABC subtype DLBCL [21,22,27]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.